QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-overweight-on-twist-bioscience-lowers-price-target-to-37

Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $4...

 twist-bioscience-eyes-profit-turnaround-in-2026-after-narrowing-losses

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.

 twist-bioscience-sees-q1-sales-100000m-101000m-vs-100337m-est

Twist Bioscience (NASDAQ:TWST) sees Q1 sales of $100.000 million-$101.000 million vs $100.337 million analyst estimate.

 twist-bioscience-sees-fy2026-sales-425000m-435000m-vs-374691m-est

Twist Bioscience (NASDAQ:TWST) sees FY2026 sales of $425.000 million-$435.000 million vs $374.691 million analyst estimate.

 twist-bioscience-q4-eps-045-misses-043-estimate-sales-99009m-beat-97317m-estimate

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(...

 stephens--co-initiates-coverage-on-twist-bioscience-with-overweight-rating-announces-price-target-of-41

Stephens & Co. analyst Steven Etoch initiates coverage on Twist Bioscience (NASDAQ:TWST) with a Overweight rating and an...

 cathie-wood-warns-wall-street-is-missing-ais-biggest-opportunity-in-healthcare-calling-it-sleeper-investment-poised-for-massive-returns

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its p...

 evercore-isi-group-maintains-outperform-on-twist-bioscience-lowers-price-target-to-42

Evercore ISI Group analyst Vijay Kumar maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price targe...

 twist-bioscience-and-element-biosciences-launch-rapid-trinity-freestyle-workflow-enabling-end-to-end-sequencing-in-5-hours-on-aviti-platforms

-- Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours ---- Twist Gain...

 cathie-woods-ark-dumps-block-stock-worth-48-million-as-bitcoin-heavy-company-preps-q2-results

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

 update-twist-bioscience-reported-q3-adj-eps-047-beats-055-estimate

Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0....

 twist-bioscience-turns-the-tide-q3-sales-jump-beats-earnings

Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA...

 twist-bioscience-sees-q4-sales-96000m-98000m-vs-99174m-est

For the fourth quarter, Twist expects: • Total revenue of approximately $96 million to $98 millionSynBio revenue of approximate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION